Verified Nov 2026
Batteries & E-Mobility
·

Dessau-Rosslau, Sachsen-Anhalt
·
Since 1921
IDT Biologika is a contract development and manufacturing organization (CDMO) headquartered in Dessau-Rosslau, Germany, founded in 1921. The company employs 1,000–5,000 people and generates an estimated $250–500 million in revenue. It specializes in development and manufacturing of biologics including viral vaccines, cell and gene therapeutics, viral vectors, and recombinant proteins. IDT operates facilities in Germany and the United States, serving pharmaceutical and biotechnology clients globally. Recent work includes partnerships on Ebola vaccine manufacturing for MSD and next-generation influenza vaccine development.
IDT Biologika at a glance
Revenue
$250-500M
Est. band
Employees
1,000-5,000
Founded
1921
Headquarters
Dessau-Rosslau, Sachsen-Anhalt
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
Overview
IDT Biologika is a contract development and manufacturing organization (CDMO) headquartered in Dessau-Rosslau, Germany, founded in 1921. The company employs 1,000–5,000 people and generates an estimated $250–500 million in revenue. It specializes in development and manufacturing of biologics including viral vaccines, cell and gene therapeutics, viral vectors, and recombinant proteins. IDT operates facilities in Germany and the United States, serving pharmaceutical and biotechnology clients globally. Recent work includes partnerships on Ebola vaccine manufacturing for MSD and next-generation influenza vaccine development.
At a glance
Attribute | Detail |
|---|---|
Founded | 1921 |
Headquarters | Dessau-Rosslau, Sachsen-Anhalt |
Employees | 1,000-5,000 |
Revenue | $250-500M (estimated) |
Primary capability | Batteries & E-Mobility |
What IDT Biologika makes
The company provides end-to-end services spanning process development, drug substance manufacturing, fill/finish operations, and regulatory support, with recognition from the U.S. FDA and European EMA.
Latest developments
2026-10-25 — IDT Deal Lifts SK Bioscience Flu, Ebola Vaccine Push - Seoul Economic Daily (sedaily.com)
2026-06-28 — IDT Eyes Capacity Expansion, M&A to Build on SK Synergies - Seoul Economic Daily (sedaily.com)
2026-04-30 — European CDMO eyes advanced therapy opportunities in Japan | Intralink (intralinkgroup.com)
2026-03-23 — IDT Biologika and SK bioscience Partner on Development and Manufacturing of Drug Product for MSD’s Zaire Ebola Vaccine with an Updated Manufacturing Process - IDT Biologika (idt-biologika.com)
2026-02-26 — IDT Biologika, SK bioscience and Vaxxas Selected for Next-Generation Influenza Vaccine Development Financed by the European Union - IDT Biologika (idt-biologika.com)
2026-02-24 — IDT Biologika looks to double its sales by 2028 in post-acquisition growth phase | Pharma Manufacturing (pharmamanufacturing.com)
Facilities
IDT Biologika is headquartered in Dessau-Rosslau, Sachsen-Anhalt. Public sources also reference these locations:
Dessau-Rosslau, Germany — idt-biologika.com
Magdeburg, Germany — idt-biologika.com
Germany — idt-corporation.com
Rockville, Maryland — idt-biologika.com
Company details
IDT operates three strategic sites across Germany and the United States and serves global pharmaceutical and biotechnology clients in vaccine development, oncolytic viruses, and advanced therapies. IDT Biologika was founded in 1921, has an estimated 1,000-5,000 employees, and is headquartered in Dessau-Rosslau, Sachsen-Anhalt.
Frequently asked questions
What does IDT Biologika make?
IDT Biologika is a contract development and manufacturing organization (CDMO) headquartered in Dessau-Rosslau, Germany, founded in 1921. The company employs 1,000–5,000 people and generates an estimated $250–500 million in revenue. It specializes in development and manufacturing of biologics including viral vaccines, cell and gene therapeutics, viral vectors, and recombinant proteins. IDT operates facilities in Germany and the United States, serving pharmaceutical and biotechnology clients globally. Recent work includes partnerships on Ebola vaccine manufacturing for MSD and next-generation influenza vaccine development.
Where is IDT Biologika headquartered?
IDT Biologika is headquartered in Dessau-Rosslau, Sachsen-Anhalt (Am Pharmapark, Dessau-Rosslau, Sachsen-Anhalt, 06861).
When was IDT Biologika founded?
IDT Biologika was founded in 1921.
How big is IDT Biologika?
IDT Biologika has an estimated 1,000-5,000 employees, with revenue in the $250-500M range (estimated).
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
